drugset / Trial / NCT06994286
The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-7117 in Chinese healthy subjects.
Timeline
- Start
- 2025-06-24
- Primary completion
- 2025-07-21
- Completion
- 2025-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dersimelagon | Small molecule | 100 mg | Oral |
| Comparator | Dersimelagon | Small molecule | 200 mg | Oral |
| Comparator | Dersimelagon | Small molecule | 300 mg | Oral |
Indications
No indication recorded.